CXCL13 and synovial sarcoma: Although further studies are needed to elucidate the mechanisms underlying the overexpression of CXCL13 and CXCL12 in epithelial cells, the present results indicate that the CD153 vaccine is also effective for preventing age- and SS-related sialadenitis.